Drug Discovery and Development

J&J and Roche named to Clarivate’s Top 100 Global Innovators list 

By |

R&D

Photo by Chokniti Khongchum from Pexels

Few healthcare companies were included in the annual ranking of innovative companies from the analytics firm Clarivate plc (NYSE:CLVT).

Two companies in pharma and another in medtech, however, made the cut.

Johnson & Johnson was featured for the second consecutive year as a top 100 Global innovator.

Roche was included for the 11th consecutive year in the report.

In medtech, Philips was included for the second consecutive year.

Clarivate notes the fragmented nature of pharmaceutical research contributes to the limited number of companies in the ranking. Given the elevated role of academia and contract firms in drug discovery and development, it is more challenging for any single entity to stand out in the industry.

Within the pharmaceutical industry, Clarivate cited the following companies as the most innovative:

Top 20, Pharmaceuticals   Region Country
Abbott Americas US
Abbvie Americas US
Amgen Americas US
AstraZeneca EMEA UK
Bayer EMEA Germany
Boehringer Ingelheim EMEA Germany
Bristol Myers Squibb Americas US
Eisai APAC Japan
Gilead Sciences Americas US
GlaxoSmithKline EMEA UK
Johnson & Johnson Americas US
Lilly Americas US
Merck Sharp & Dohme Americas US
Novartis EMEA Switzerland
Novo Nordisk EMEA Denmark
Otsuka Pharmaceutical APAC Japan
Pfizer Americas US
Roche EMEA Switzerland
Sanofi EMEA France
Takeda Americas Japan

 

Filed Under: Drug Discovery, Drug Discovery and Development
Tagged With: , , , , , , , , , , , , , , , , , , , , ,
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Search Drug Discovery & Development